Explore More Than Just This Free Article

This article is a glimpse of the exclusive insights we provide daily to industry leaders. Dive deeper into our industry-specific reports and uncover the strategic information you need.

Evonik announces certification of its VISIOMER Terra methacrylate monomers by DIN CERTCO certification body; recognition is based on adherence to certain protocols for calculating biobased content

March 23, 2023 (press release) –

 

Use of the DIN CERTCO mark only in connection with the certified products mentioned in the press release

Essen, Germany. The bio-content of VISIOMER® Terra methacrylate monomers is now certified by DIN CERTCO―the certification body of TÜV Rheinland Group―and will include the label “Certified Biobased Product.” DIN CERTCO certifies products using the C14 radiocarbon method and ASTM D 6866:2021 protocol instead of merely calculating the bio-content.

VISIOMER® Specialty Methacrylates are among the most versatile and efficient building blocks of macromolecular chemistry. They serve a broad range of industries and applications and enable individual and sustainable effects for products in adhesives, paints and coatings, among others. Evonik focuses on customized and innovative solutions for replacing hazardous or harmful substances, facilitating weight reduction in composites and reducing carbon footprint.

VISIOMER® Terra monomers contain up to 85 percent bio-content and must meet the highest performance requirements as well as have a low hazard potential. Expanding the portfolio of VISIOMER® Terra biobased monomers is part of Evonik’s long-term strategy to protect the environment and mitigate climate change without compromising performance.

In addition to DIN CERTCO certification, VISIOMER® Terra products are supported by detailed Life Cycle Assessments (LCAs) according to ISO 14040/14044. LCAs are a critical tool assessing various environmental impacts of VISIOMER® Terra Specialty Methacrylates throughout their production and support Evonik customers in benchmarking their own products.

“At Evonik we strive to minimize the environmental footprint of our own product while maximizing the handprint in the application. We are energized to develop products with superior sustainability benefits, so called next-generation solutions, in close collaboration with all partners along the value chain. For this purpose, we provide our customers with data from our Life Cycle Assessments”, says Alexander Kehl, Head of Specialty Methacrylates product line.

The portfolio of VISIOMER® Terra products is expanding and includes biobased equivalents of well-known monomers as well as new structures from readily available, biobased feedstocks. 

You can find the DIN CERTCO certificate of VISIOMER® Terra products here

For more information please visit www.visiomer.com

Visit us at the European Coatings Show from March 28-30 in Nuremberg. You can find us in hall 3C at booth 426. Dr. Christine Breiner will give a presentation on sustainable VISIOMER® Methacrylates, on Wednesday, March 29, 04:10 pm, in hall 3A at booth 607. For more information about Evonik at the ECS please visit: https://coatings.evonik.com/en

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €18.5 billion and an operating profit (adjusted EBITDA) of €2.49 billion in 2022. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 34,000 employees work together for a common purpose: We want to improve life today and tomorrow.

The Specialty Additives division combines the businesses of versatile additives and high-performance crosslinkers. They make end products more valuable, more durable, save more energy and simply better. As formulation experts in fast growing markets such as coatings, mobility, infrastructure and consumer goods, Specialty Additives combines a small amount with a big effect. With its 3,800 employees the division generated sales of €4.18 billion in 2022.  

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo with Chelsey
Chelsey Quick
Chelsey Quick
- VP Client Success -

We offer built-to-order bioeconomy coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

This website stores cookies on your computer. These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy. We won't track your information when you visit our site. But in order to comply with your preferences, we'll have to use just one tiny cookie so that you're not asked to make this choice again.